Eli Lilly Slams Suit Alleging Shortage Of Weight-Loss Drug

By Dan McKay · January 2, 2025, 5:47 PM EST

Eli Lilly is seeking permission to join a legal fight over whether compounding pharmacies can keep making copycat versions of the company's lucrative weight-loss and diabetes drug, telling a federal court...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Outsourcing Facilities Association et al v. United States Food and Drug Administration et al

Case Number

Court

Texas Northern

Nature of Suit

Other Statutes: Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

October 07, 2024

Recent Articles By Dan

December 20, 2024
3rd Circ. Denies Challenge To Pa. Autism Settlement
December 19, 2024
FDA Declaration May Restart Compounders' Shortage Suit
December 17, 2024
New Fed Health Data Rules: What You Need To Know
December 17, 2024
FDA Sharpens Focus On Celebrity Drug Endorsements
December 10, 2024
FDA Drug Approval Guidance: What You Need to Know
December 09, 2024
19 Republican AGs Win Order Against DACA Health Coverage
December 03, 2024
GOP-Backed Medicaid Job Mandate Could Reshuffle Care
November 26, 2024
Trump FDA Pick Devoted To Healthcare Price Transparency
November 19, 2024
No 'Tin Hats': Fluoride Ruling Offers Options As RFK Eyes Ban
November 15, 2024
Teva Defends Mifepristone Antitrust Case Against Corcept